Kaldalón hf. has completed the sale of unsecured six-month bills in series KALD 26 0901. Offers were received totaling ISK 1,340 million, with flat interest rates ranging from 7,95% to 8.58% per annum. Bills with a nominal value of ISK 1,040 million were sold at an interest rate of 8.04%. The payment and settlement date is Monday, 1 March 2026. An application will be submitted for the bills to be admitted to trading on the Nasdaq Iceland Main Market, and the first trading day will be announced with at least ...

HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Abits Group Inc (NASDAQ: ABTS) (the “Company”), a new generation digital center with inhouse bitcoin mining operations, today announced the closing of the previously announced registered direct offering with institutional investors of approximately $2.1 million of Ordinary Shares and pre-funded warrants at a price of $2.65 per Ordinary Share. The entire transaction was priced at the market under Nasdaq rules. The offering consisted of the sale of 792,452 Ordinary ...

PRESS RELEASE AB SCIENCE ANNOUNCES THE IDENTIFICATION OF A PLASMA BIOMARKER THAT INDICATES THE ACTIVITY OF MASITINIB IN TREATING AMYOTROPHIC LATERAL SCLEROSIS, AND THAT IS CAPABLE OF IDENTIFYING PATIENTS WITH PRO INFLAMATORY MICROGLIA, WHICH ARE TARGETED BY MASITINIB THIS BIOMARKER IS ALSO APPLICABLE TO PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS AND ALZHEIMER DISEASE THIS BIOMARKER CAN BE STRATEGIC TO DETERMINE WHICH PATIENTS RESPOND TO TREATMENT AND POTENTIALLY INCREASE CHANCE OF REGISTRATION IN NEURODEGENER ...

Webcast and Conference Call to take place on Friday, 27 March 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ETGhent, BELGIUM, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its annual report and consolidated financial results for the full year of 2025 on Friday, 27 March 2026 at 07:00 CET. Webcast and Conference Call In additi ...

SAN FRANCISCO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Uber Health today announced the launch of its rider self-booking feature, a new platform capability that enables healthcare and disability service organizations to offer their riders the ability to book their own organization-funded trips directly in the Uber app. The launch marks the latest milestone in Uber Health’s efforts to modernize patient and nonmedical transportation (NMT) to make healthcare more accessible, convenient, and easy to navigate.  Self-bo ...

BENSALEM, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to howardsmith@howardsmithla ...

2025 results in line with guidanceLaunch of Horizons strategic plan Paris, February 24th, 2026 - Ipsos, one of the world's leading market research and opinion polling companies, today announces its full-year 2025 results. Revenue, organic growth and operating margin rate, communicated on a preliminary basis at the Investor Day on 22 January, are confirmed. Revenue: €2,525 million Total growth: +3.4%Organic growth: +0.6% Operating margin: €309 million Operating margin rate: 12.3%Operating margin rate at cons ...

Marimekko Corporation, Stock Exchange Release, 24 February 2026 at 6.45 p.m. EET Marimekko Corporation: Repurchase of own shares on 24 February 2026 Marimekko Corporation (LEI: 74370053IOY42B9YJ350) has acquired its own shares (ISIN FI0009007660) as follows: Trade date24 February 2026Bourse tradeBuyShareMEKKOVolume8,200Average price/share, EUR11.3280Total price, EUR92,889.60 On 12 February 2026, Marimekko announced that it will start acquiring the company’s own shares based on the authorization granted by t ...

Core Insights - BIC faced a challenging year in 2025, with net sales of €2,090 million, a decrease of 0.9% at constant currency and 4.7% on a comparative basis, primarily due to difficulties in the US market [2][11] - The company reported an adjusted EBIT of €283 million, down from €343 million in 2024, resulting in an adjusted EBIT margin of 13.6% [3][44] - Adjusted EPS fell to €4.74 from €6.15 in 2024, while free cash flow generation was resilient at €222 million compared to €271 million in the previous year [4][9] Financial Performance - Q4 2025 net sales were €495 million, reflecting a 1.1% increase at constant currency but a 2.3% decline on a comparative basis [2][11] - The gross profit margin for FY 2025 was 48.8%, down from 50.2% in FY 2024, influenced by higher raw material costs and unfavorable currency fluctuations [12][11] - Non-recurring items for FY 2025 amounted to €127 million, significantly higher than €53 million in 2024, primarily due to the disposal of Cello activities in India and the discontinuation of certain product lines [14][11] Strategic Actions and Leadership - A renewed governance and executive leadership team has been established to guide BIC's next phase of growth, with initial strategic actions launched in H2 2025 to streamline the portfolio [5][6] - The integration of Tangle Teezer has been successful, achieving double-digit growth in its first year within BIC [6] - The company is focused on simplifying and transforming its organization to drive sustainable profitable growth and long-term value creation [7][10] Shareholder Returns - BIC announced an ordinary dividend of €2.40 per share for FY 2025, representing a total payout of approximately €98 million with a pay-out ratio of 51% [8] - A renewed share buyback program of up to €40 million is planned for execution in 2026 [8] Market Performance by Division - The Human Expression division saw net sales decline by 9.6% for FY 2025, primarily due to poor performances in Latin America and the US [25][26] - The Flame for Life division experienced a 10.8% decrease in net sales for FY 2025, negatively impacted by weak performance in North and Latin America [33][36] - The Blade Excellence division reported a 10.8% increase in net sales for FY 2025, driven by the strong performance of Tangle Teezer [37][39]

Group 1 - VINCI SA conducted share buybacks from February 16 to February 20, 2026, under the authorization from the General Meeting held on April 17, 2025 [2] - A total of 73,759 shares were purchased during this period, with an aggregated daily weighted average price of €137.8995 [2] - The transactions were executed across multiple markets, including XPAR, CEUX, AQEU, and TQEX, with varying volumes and prices each day [2][3] Group 2 - On February 16, 2026, VINCI purchased a total of 14,883 shares across different markets, with prices ranging from €136.0962 to €136.2276 [2] - On February 17, 2026, the company bought 14,809 shares, with prices between €137.0797 and €137.1363 [2] - On February 18, 2026, VINCI acquired 14,687 shares, with prices from €138.0291 to €138.1561 [2] - On February 19, 2026, the total shares purchased were 14,715, with prices ranging from €138.3512 to €138.4461 [2] - On February 20, 2026, VINCI bought 14,665 shares, with prices between €139.7994 and €139.9446 [2]